MAPT and Alzheimer disease: Although we also performed immunizations using AD-PHF Tau and peptides targeting known disease-associated phospho-epitopes, we were surprised to discover that the most efficacious antibody (antibody D) arose from immunization with recombinant, non-phosphorylated Tau.